Harvard Ave Acquisition CorpHAVA
Cash in trust
$148.6M
$148,612,304
Trust per share
$10.25
Redemption value
IPO
Oct 2025
$145.0M raised
Combination deadline
Apr 22, 2027
230 days remaining
Filings on record
44
Latest Aug 15, 2026
Overview
Harvard Ave Acquisition Corp is a special purpose acquisition company incorporated in Cayman Islands and registered with the SEC under CIK 0002042460. It completed its initial public offering in Oct 2025, raising $145.0M in gross proceeds and listing on Nasdaq. Class A shares trade under the ticker HAVA, units under HAVAU, rights under HAVAR on Nasdaq. The vehicle is sponsored by Harvard Ave. The mandate targets generalist. IPO closed, trust funded, no definitive agreement announced.
“We intend to seek to acquire a target on terms and in a manner that leverages our experience.”
Reading the filings
Arithmetic on what Harvard Ave Acquisition Corp has disclosed, written the way a desk would read it. These are observations, not a rating. Nothing here scores the vehicle or implies a view on it.
Trading at a discount to trust
At $10.23 the shares sit within a point of the $10.25 redemption value, so the market is pricing the cash and little else.
Trust versus the $10 unit
The trust holds $10.25 per public share, 2.5% above the $10.00 the units were sold at. That spread is accrued interest on the trust and, where the charter provides for it, sponsor contributions paid in to buy more time. It is the floor a public shareholder can redeem at, not a valuation of the business.
Time on the clock
230 days to the Apr 22, 2027 deadline. Still workable for a deal already in diligence, tight for one that has not been found. Watch for an extension proxy, which typically appears a month or two before the date.
Underwriting
D. Boral Capital led the offering. It has been named on 28 SPAC IPOs, book-running 27 of them. The syndicate has no control over whether a sponsor finds a target, but the quality of the book at pricing shapes who ends up holding the units.
Scores
Recomputed 4m agoThree readings of Harvard Ave Acquisition Corp, each an unweighted mean of the components shown beneath it, and each component a percentile against every live SPAC rather than an absolute we invented. They describe the setup, not the merit. How they are built
Edge
ModerateHow much does the structure protect a holder right now?
46/100
- Discount to trust56
0.20%
- Trust accretion53
$10.25 per share
- Runway29
230 days
Edge reads the setup, not the business. A vehicle can score well on protection and still be a poor place to leave money once a deal closes.
FOMO
ModerateHow much attention is this vehicle attracting right now?
27/100
- Filing activity38
2 in 30 days
- News coverage0
0 stories in 30 days
- Premium to trust44
-0.20%
Attention is not quality. FOMO rises on news volume and on the market paying above trust, both of which have preceded plenty of disappointments.
Potential
ModerateHow likely is this vehicle to complete a combination, and at what scale?
33/100
- Bank franchise26
28 SPAC mandates
- Trust scale32
$149M
- Stage40
searching
Potential is about execution, not about the target. It says nothing about whether the eventual deal is worth owning, because the target is usually unknown when the score is computed.
These are derived measures, not ratings of investment merit. They carry no view on the target, no price target and no recommendation, and a high score is not a reason to buy anything.
SEC filing history
Free tier: filings older than 24 hours- SCHEDULE 13G
Beneficial ownership report (passive)
Accession 0001326389-26-000070
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0000886982-26-000447
- 10-Q
Quarterly report
Accession 0001213900-26-082816
- SCHEDULE 13G
Beneficial ownership report (passive)
Accession 0001140361-26-021481
- 10-Q
Quarterly report
Accession 0001213900-26-053891
- SCHEDULE 13G
Beneficial ownership report (passive)
Accession 0000886982-26-000150
- 10-K
Annual report
Accession 0001213900-26-034730
- 8-K
Other events
Items 8.01, 9.01 · Accession 0001213900-25-119662
- 10-Q
Quarterly report
Accession 0001213900-25-110033
- 8-K
Other events
Items 8.01, 9.01 · Accession 0001213900-25-104229
- 3
Initial statement of beneficial ownership
Accession 0001213900-25-104125
- SCHEDULE 13G
Beneficial ownership report (passive)
Accession 0001104659-25-103718
- SCHEDULE 13D
Beneficial ownership report (activist)
Accession 0001213900-25-102636
- SCHEDULE 13D
Beneficial ownership report (activist)
Accession 0001213900-25-102633
- 8-K
Entry into a material definitive agreement; Other events
Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01 · Accession 0001213900-25-102570
- 3
Initial statement of beneficial ownership
Accession 0001213900-25-102263
- 3
Initial statement of beneficial ownership
Accession 0001213900-25-102221
- 3
Initial statement of beneficial ownership
Accession 0001213900-25-102218
- 3
Initial statement of beneficial ownership
Accession 0001213900-25-102217
- 3
Initial statement of beneficial ownership
Accession 0001213900-25-102216
- 3
Initial statement of beneficial ownership
Accession 0001213900-25-102215
- 424B4
Final IPO prospectus
Accession 0001213900-25-101309
- CERT
CERTIFICATION, FILED 10/22/2025
Accession 0001354457-25-001050
- EFFECT
Notice of effectiveness
Accession 9999999995-25-003165
- 8-A12B
Registration of securities on an exchange
Accession 0001213900-25-094036
- CORRESP
Correspondence with SEC staff
Accession 0001213900-25-092643
- CORRESP
Correspondence with SEC staff
Accession 0001213900-25-092642
- CORRESP
Correspondence with SEC staff
Accession 0001213900-25-091548
- S-1/A
Amended IPO registration statement
Accession 0001213900-25-091541
- UPLOAD
SEC staff comment letter
Accession 0000000000-25-010389
Harvard Ave Acquisition Corp: questions answered
What is Harvard Ave Acquisition Corp (HAVA)?
Harvard Ave Acquisition Corp is a special purpose acquisition company incorporated in Cayman Islands and registered with the SEC under CIK 0002042460. It completed its initial public offering in Oct 2025, raising $145.0M in gross proceeds and listing on Nasdaq. Class A shares trade under the ticker HAVA, units under HAVAU, rights under HAVAR on Nasdaq. The vehicle is sponsored by Harvard Ave. The mandate targets generalist. IPO closed, trust funded, no definitive agreement announced.
How much does Harvard Ave Acquisition Corp hold in trust?
Approximately $148,612,304, or about $10.25 per public share, as at the most recent filing on record. Trust balances move: shareholders redeem at extension votes and at the combination vote, and sponsors pay contributions in to extend. Treat the figure as a point-in-time disclosure, not a running balance.
When must Harvard Ave Acquisition Corp complete a merger?
By Apr 22, 2027. If no combination closes by then the sponsor must seek a further extension or wind the vehicle up and return the trust.
What happens if Harvard Ave Acquisition Corp does not find a target in time?
The charter requires the vehicle to redeem 100% of the public shares and return the trust, pro rata, to public shareholders. That is the mechanism working as designed rather than a default. Founder shares and warrants are worthless in that outcome, which is why the sponsor's incentive is to get a deal done or to buy more time. Across the market, deadline lapsed without a deal; trust returned to public shareholders.
Can I redeem shares in Harvard Ave Acquisition Corp, and at what price?
Public shareholders may elect to redeem in connection with a combination vote and at each extension vote, at the pro-rata trust value on the relevant record date, most recently disclosed at about $10.25 per share. Redemption is a right attached to the public shares only; warrants and rights carry no claim on the trust. The mechanics and the deadline for electing are set out in the proxy statement for the vote in question.
What tickers does Harvard Ave Acquisition Corp trade under?
Class A shares trade as HAVA on Nasdaq, the units as HAVAU, with rights as HAVAR. Units trade first and separate into their component securities roughly 52 days after the IPO; only the Class A shares carry the redemption right against the trust.
Is the trust value the same as the share price for Harvard Ave Acquisition Corp?
No, and the gap between them is the whole trade. Trust per share is a disclosed, contractual figure of $10.25, being what a redeeming holder receives. The market price is whatever the shares change hands at: most recently $10.23, a discount of 0.20% to the redemption value. Quotes on this site are delayed and indicative; confirm on your own venue before trading.
Who sponsors Harvard Ave Acquisition Corp, and what is their track record?
Harvard Ave is the sponsor entity, part of the Harvard Ave franchise. This is the only vehicle we have attributed to that sponsor. Named principals: Sung Hyuk Lee.
Which banks underwrote the Harvard Ave Acquisition Corp IPO?
D. Boral Capital. D. Boral Capital was credited as book-running manager on the cover. Syndicate membership and role are read from the prospectus cover and the underwriting section.
Is Harvard Ave Acquisition Corp tradeable, and where?
Yes. HAVA returned a live quote of $10.23 on Nasdaq. Quotes here are delayed and refreshed on a schedule rather than streamed, so treat the figure as indicative and confirm on your own venue. Units and warrants trade under their own symbols and are quoted separately.
Is Harvard Ave Acquisition Corp a good investment?
That is not a question this site answers. Harvard Ave Acquisition Corp is covered here as reference data: what the company filed, when it filed it, and what the numbers in those filings say. The Edge, FOMO and Potential scores on this page are derived measures with a published formula, not ratings of investment merit: they describe the setup, and every component is shown so you can take them apart. We publish no price targets and no recommendations, and nothing here should be read as advice. The figures are a starting point for your own work, and each one carries the accession number of the filing it came from.
Where does this Harvard Ave Acquisition Corp data come from?
Filings Harvard Ave Acquisition Corp submitted to the SEC under CIK 0002042460: the registration statement and final prospectus for the structure, quarterly and annual reports for the trust, current reports and proxy statements for deals, votes and extensions. Trust economics are taken from the registrant's own XBRL tags rather than parsed from prose, which is why they are exact. Every filing in the history above is listed with its accession number, which identifies the document uniquely on EDGAR; Pro accounts open it directly from the row.
Compiled by the SPACListing research desk
Last reconciled Sep 4, 2026
Every figure on this page is read from documents the registrants filed with the U.S. Securities and Exchange Commission, principally the IPO prospectus (Form 424B4), quarterly and annual reports, current reports and proxy statements, the registrant's own XBRL tags for trust economics. Nothing is sourced from press coverage, from the companies themselves, or from a third-party aggregator. Where a filing does not disclose something, the field is left blank rather than estimated.
Read the full methodology · What is in the dataset · Report a correction
SPACListing is a reference-data service, not an investment adviser. Nothing here is a recommendation to buy or sell any security.
Continue reading
The context around this vehicle: who else the sponsor has launched, which banks priced it, and where it sits in the wider market.
Harvard Ave: the full record
Every vehicle this sponsor has launched, what closed, what liquidated and what is still live.
D. Boral Capital in SPACs
Mandates, bookrun credit, deal volume and the outcome of the vehicles it priced.
Generalist SPACs
Every vehicle chasing the same mandate, ranked by cash in trust.
All spacs searching for a target
IPO closed, trust funded, no definitive agreement announced.
Deadline calendar
Which sponsors are running out of time, and when the extension votes land.
What is a SPAC?
The structure, the economics and where the risks actually sit.
SPAC glossary
Every term in a blank-check filing, defined the way practitioners use it.
How this data is built
Coverage universe, ingestion, normalisation, lifecycle classification and known limits.